New missense mutation in the alpha-sarcoglycan gene in a Japanese patient with severe childhood autosomal recessive muscular dystrophy with incomplete alpha-sarcoglycan deficiency

J Neurol Sci. 1997 Dec 9;153(1):100-5. doi: 10.1016/s0022-510x(97)00182-2.

Abstract

A new homozygous alpha-sarcoglycan (adhalin) gene mutation was found in a Japanese patient with severe childhood autosomal recessive muscular dystrophy (SCARMD). Muscle biopsy specimens from the patient showed marked reduction but not complete deficiency of alpha-sarcoglycan. The sequence of part of exon 3 of the alpha-sarcoglycan gene exhibited a cytosine to thymidine substitution at nucleotide position 220. Since the same mutation was not found in 100 normal control samples, this new alpha-sarcoglycan gene mutation is not a polymorphism but is presumed to be responsible for the marked reduction of alpha-sarcoglycan in skeletal muscle. Most patients with homozygous alpha-sarcoglycan gene mutation were reported to show complete alpha-sarcoglycan deficiency. Present case showed the homozygous missense mutation of alpha-sarcoglycan and associated with incomplete alpha-sarcoglycan deficiency and severe clinical phenotype.

Publication types

  • Case Reports

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology
  • Adult
  • Chromosome Aberrations
  • Chromosome Disorders
  • Cytoskeletal Proteins / deficiency*
  • Cytoskeletal Proteins / genetics*
  • Electromyography
  • Genes, Recessive / genetics
  • Humans
  • Immunohistochemistry
  • Male
  • Membrane Glycoproteins / deficiency*
  • Membrane Glycoproteins / genetics*
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Muscular Dystrophies / genetics*
  • Muscular Dystrophies / metabolism
  • Muscular Dystrophies / pathology
  • Mutation / physiology*
  • Neural Conduction / physiology
  • Polymerase Chain Reaction
  • Sarcoglycans

Substances

  • Cytoskeletal Proteins
  • Membrane Glycoproteins
  • Sarcoglycans